Citi, Jefferies Weigh In On Biogen Idec Amid Q3 Earnings By: Benzinga via Benzinga October 23, 2014 at 11:25 AM EDT Biogen Idec Inc (NASDAQ: BIIB) reported third quarter revenues of $2.5 billion and an EPS of $3.80. Following the report, a number of ... Read More >> Related Stocks: Biogen Idec